A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101

Summary

Safety and tolerability study of 2 concentrations of QLS-101 for adult subjects with Sturge Weber Syndrome (SWS)-related glaucoma due to elevated episcleral venous pressure (EVP).

Timeline

Start

2021-10-19

Primary completion

2022-06-06

Completion

2022-08-01

Drugs

Indications